Look at the volumes in 2013 before and after the Assure trial failure...2.5 million, 5 even 10 million shares trading in a single day. Now RVX barely makes it to 1 million trading on occasion...and on the uptrend the norm is about 200K. This is despite there being about 10 million more OS now.

Of course being a TSX listed company with our only US exposure being OTC....I think a nasdaq listing would help immensely, and with the PPS threatening $3 in the near term that looks like it could very well come to fruition.